These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37818745)

  • 1. NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
    Chen X; Hao Y; Liu Y; Zhong S; You Y; Ao K; Chong T; Luo X; Yin M; Ye M; He H; Lu A; Chen J; Li X; Zhang J; Guo X
    Adv Sci (Weinh); 2023 Nov; 10(32):e2302705. PubMed ID: 37818745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.
    Li G; Ma X; Sui S; Chen Y; Li H; Liu L; Zhang X; Zhang L; Hao Y; Yang Z; Yang S; He X; Wang Q; Tao W; Xu S
    J Exp Clin Cancer Res; 2024 Oct; 43(1):278. PubMed ID: 39363363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.
    Liu H; Xu L; Yue S; Su H; Chen X; Liu Q; Li H; Liang H; Chen X; He J; Ding Z; Zhang B
    Cancer Commun (Lond); 2024 Sep; 44(9):1018-1041. PubMed ID: 39030964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
    Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P
    Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression.
    Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y
    J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
    Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
    Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT10 mediated ac4C acetylation driven m
    Mei Z; Shen Z; Pu J; Liu Q; Liu G; He X; Wang Y; Yue J; Ge S; Li T; Yuan Y; Yang L
    Cell Commun Signal; 2024 Jan; 22(1):51. PubMed ID: 38233839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA.
    Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W
    J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.
    Zhao CC; Sun X; Chen J; Geng BD
    Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.
    Yang Q; Lei X; He J; Peng Y; Zhang Y; Ling R; Wu C; Zhang G; Zheng B; Chen X; Zou B; Fu Z; Zhao L; Liu H; Hu Y; Yu J; Li F; Ye G; Li G
    Adv Sci (Weinh); 2023 Aug; 10(23):e2300898. PubMed ID: 37328448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of NAT10 Reduces the Translation of
    Xu T; Du T; Zhuang X; He X; Yan Y; Wu J; Zhou H; Li Y; Liao X; He J; Liu C; Dong Y; Ou J; Lin S; Chen D; Huang ZP
    J Am Heart Assoc; 2024 Oct; 13(20):e035714. PubMed ID: 39392166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA.
    Li Z; Li D; Yang T; Yao C
    Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9.
    Ding M; Yu Z; Lu T; Hu S; Zhou X; Wang X
    Clin Transl Med; 2024 Jul; 14(7):e1747. PubMed ID: 38961519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation.
    Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X
    Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.
    Xie R; Cheng L; Huang M; Huang L; Chen Z; Zhang Q; Li H; Lu J; Wang H; Zhou Q; Huang J; Chen X; Lin T
    Cancer Res; 2023 May; 83(10):1666-1683. PubMed ID: 36939377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells.
    Liu R; Wubulikasimu Z; Cai R; Meng F; Cui Q; Zhou Y; Li Y
    Nucleic Acids Res; 2023 Sep; 51(16):8514-8531. PubMed ID: 37497776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway.
    Liu Y; Wang X; Liu Y; Yang J; Mao W; Feng C; Wu X; Chen X; Chen L; Dong P
    Cell Death Dis; 2023 Nov; 14(11):712. PubMed ID: 37914704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.
    Qin G; Bai F; Hu H; Zhang J; Zhan W; Wu Z; Li J; Fu Y; Deng Y
    Mol Med; 2024 Jan; 30(1):13. PubMed ID: 38243170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
    Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
    Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.
    Wei W; Zhang S; Han H; Wang X; Zheng S; Wang Z; Yang C; Wang L; Ma J; Guo S; Wang J; Liu L; Choe J; Lin S
    Cell Rep; 2023 Jul; 42(7):112810. PubMed ID: 37463108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.